Vical Incorporated Grants Johns Hopkins Bloomberg School of Public Health Academic License for Core Technology

SAN DIEGO, May 14, 2009 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company has granted a non-exclusive, academic license for its broad DNA delivery technology patent estate to the Johns Hopkins Bloomberg School of Public Health. The company had previously announced the grant of academic licenses on the same terms to Stanford University, Harvard University, Yale University, the Massachusetts Institute of Technology, and six additional leading academic research institutions.

Back to news